PULSE BIOSCIENCES ($PLSE) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.28 per share, missing estimates of -$0.27 by $0.01. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $PLSE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PULSE BIOSCIENCES Insider Trading Activity
PULSE BIOSCIENCES insiders have traded $PLSE stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PLSE stock by insiders over the last 6 months:
- DARRIN UECKER (Chief Technology Officer) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $485,700.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PULSE BIOSCIENCES Hedge Fund Activity
We have seen 35 institutional investors add shares of PULSE BIOSCIENCES stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 380,693 shares (+45.2%) to their portfolio in Q2 2025, for an estimated $5,744,657
- INVESCO LTD. removed 214,490 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $3,451,144
- MILLENNIUM MANAGEMENT LLC added 86,574 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,392,975
- RENAISSANCE TECHNOLOGIES LLC added 67,800 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,090,902
- STATE STREET CORP removed 55,006 shares (-11.6%) from their portfolio in Q1 2025, for an estimated $885,046
- SQUAREPOINT OPS LLC added 51,418 shares (+inf%) to their portfolio in Q1 2025, for an estimated $827,315
- GEODE CAPITAL MANAGEMENT, LLC added 33,744 shares (+7.2%) to their portfolio in Q2 2025, for an estimated $509,196
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
